Department of Vascular Surgery, Helsingborg Regional Hospital, Helsingborg, Sweden; Vascular Center, Skåne University Hospital Malmö, Malmö, Sweden.
Vascular Center, Skåne University Hospital Malmö, Malmö, Sweden.
J Vasc Surg. 2019 Dec;70(6):1747-1753. doi: 10.1016/j.jvs.2019.01.078. Epub 2019 Jul 18.
The treatment strategy for proximal aortic disease or type I endoleak after previous infrarenal repair has traditionally been open surgery. As endovascular treatment options with fenestrated and branched stent grafts increasingly rival open surgery for juxtarenal and pararenal aortic aneurysms, secondary proximal repair may similarly be performed endovascularly. Fenestrated stent grafts are individually tailored to each patient, whereas a more readily available "off-the-shelf" branched stent graft is often suitable in more urgent settings.
All patients who had been reoperated on with a proximal fenestrated or branched cuff after previous infrarenal endovascular or open repair from two tertiary referral centers between 2002 and 2015 were included in the analysis. Patients were retrospectively enrolled in a digital database. Data were collected from chart review and digital imaging.
There were 43 patients, 37 (86%) male and six (14%) female, who were treated. The indications for proximal endovascular repair were type I endoleak (58%), proximal aneurysm formation (30%), and stent graft migration (12%). Median follow-up time was 33 months (range, 3-120 months); 34 patients (79%) received a fenestrated cuff, and branched stent grafts were used in 8 (19%) cases. The majority of grafts had three (47%) or four (49%) fenestrations or branches. Technical success was accomplished in 93% of cases. In two cases, the celiac trunk occluded; in one case, the hepatic artery was overstented, and a renal artery could not be cannulated in one case. Median hospital stay was 5 days (range, 2-57 days). The 30-day mortality was 0%, and 1-year mortality was 5%. One patient died of an aneurysm-related cause during the study period.
An endovascular approach with fenestrated or branched stent grafts for treatment of proximal endoleak, proximal aneurysm formation, or pseudoaneurysms after previous infrarenal repair seems to be a valid alternative to open surgery.
传统上,对于先前肾下修复后的近端主动脉疾病或 I 型内漏,治疗策略是开放手术。随着血管内治疗选择(带开窗和分支支架移植物)对于肾周和肾旁主动脉瘤越来越与开放手术相媲美,继发性近端修复也可能通过血管内方式进行。开窗支架移植物是根据每个患者的个体情况定制的,而更易于获得的“现成”分支支架移植物通常在更紧急的情况下更为合适。
在 2002 年至 2015 年间,两个三级转诊中心对先前肾下血管内或开放修复后再次接受近端开窗或分支袖口修复的所有患者进行了分析。患者通过数字数据库进行回顾性登记。数据从图表审查和数字成像中收集。
共有 43 名患者(37 名男性,占 86%,6 名女性,占 14%)接受了治疗。近端血管内修复的适应证为 I 型内漏(58%)、近端动脉瘤形成(30%)和支架移植物迁移(12%)。中位随访时间为 33 个月(范围,3-120 个月);34 名患者(79%)接受了开窗袖口,8 名患者(19%)使用了分支支架移植物。大多数移植物有三个(47%)或四个(49%)的开窗或分支。93%的病例达到了技术成功。有两例患者腹腔干闭塞,一例患者肝动脉过度扩张,一例患者无法对肾动脉进行插管。中位住院时间为 5 天(范围,2-57 天)。30 天死亡率为 0%,1 年死亡率为 5%。在研究期间,有 1 名患者死于与动脉瘤相关的原因。
对于先前肾下修复后近端内漏、近端动脉瘤形成或假性动脉瘤的治疗,采用开窗或分支支架移植物的血管内方法似乎是开放手术的有效替代方案。